Cibc Asset Management Inc Sarepta Therapeutics, Inc. Transaction History

Cibc Asset Management Inc

$28 Billion
Q4 2024

A detailed history of Cibc Asset Management Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Cibc Asset Management Inc holds 2,851 shares of SRPT stock, worth $324,215. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,851

Previous 2,712 5.13%

Holding current value

$324,215

Previous $338,000 2.37%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$104.54 - $137.94 $14,531 - $19,173	139 Added 5.13%	2,851 $346,000
Q3 2024 Nov 06, 2024	BUY	$124.33 - $156.75 $10,692 - $13,480	86 Added 3.27%	2,712 $338,000
Q2 2024 Aug 01, 2024	BUY	$113.33 - $163.85 $35,812 - $51,776	316 Added 13.68%	2,626 $414,000
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $5,758 - $7,643	49 Added 2.17%	2,310 $318,000
Q4 2022 Feb 13, 2023	SELL	$100.86 - $132.13 $12.6 Million - $16.5 Million	-124,714 Reduced 98.22%	2,261 $292,000
Q3 2022 Nov 03, 2022	BUY	$75.71 - $119.24 $9.39 Million - $14.8 Million	123,961 Added 4112.84%	126,975 $14 Million
Q2 2022 Aug 09, 2022	SELL	$62.69 - $88.44 $12.2 Million - $17.2 Million	-193,955 Reduced 98.47%	3,014 $226,000
Q4 2021 Feb 08, 2022	SELL	$77.28 - $99.42 $8.36 Million - $10.8 Million	-108,162 Reduced 35.45%	196,969 $17.7 Million
Q3 2021 Nov 09, 2021	BUY	$65.97 - $92.48 $2.03 Million - $2.84 Million	30,751 Added 11.21%	305,131 $28.2 Million
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $18.8 Million - $23.5 Million	271,466 Added 9315.92%	274,380 $21.3 Million
Q1 2021 May 14, 2021	BUY	$72.25 - $168.95 $8,525 - $19,936	118 Added 4.22%	2,914 $217,000
Q3 2020 Nov 05, 2020	BUY	$127.12 - $172.34 $8,771 - $11,891	69 Added 2.53%	2,796 $393,000
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $208,697 - $369,726	2,727 New	2,727 $352,000
Q3 2019 Oct 30, 2019	SELL	$72.81 - $156.91 $168,700 - $363,560	-2,317 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$71.74 - $153.69 $166,221 - $356,099	2,317 New	2,317 $306,000

Others Institutions Holding SRPT

# of Institutions

525

Shares Held

84.4M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Account

Cibc Asset Management Inc Sarepta Therapeutics, Inc. Transaction History